System operational · UK tenders
Awarded
ocds-h6vhtk-05193a · award

NHS National Generic Pharmaceuticals - Wave 15c

NHS England

Estimated Value

£17,727,000 – £403,702,000

Deadline

10 October 2025

Published

26 February 2026

Type

Not specified

LondonGBopen

Overview

NHS National Framework for Generic Pharmaceuticals - Wave 15c Offer reference number: CM/PHG/23/5699 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/01 Oral (plus non-parenteral) products CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months) CM/PHG/23/5699/02 Hospital only products DLS: 01/06/2026 to 31/05/2028 (24 months) DNE: 01/06/2026 to 31/05/2028 (24 months) CM/PHG/23/5699/03 Hospital only (housekeeping) products DLN/DNW 01/06/2026 to 31/01/2027 (8 months) DCE/DSW 01/06/2026 to 30/09/2027 (16 months)

AI AnalysisMembers

Requirements, key tasks and tips for reading this tender — included with Tendarix membership.

Create free account

£4.99/month after a 7-day free trial. Cancel anytime before it ends and you pay nothing.

Award Details

Amarox Limited

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Brown & Burk UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Celix Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Cipla

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Consilient Health Ltd

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Dr.Reddy's Laboratories (UK) Limited

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Farmak Pharmaceuticals

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Morningside Pharmaceuticals

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

VIATRIS UK HEALTHCARE LIMITED

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Novumgen Limited

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Roche Products Ltd

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Rosemont Pharmaceuticals Limited

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

RPH Pharmaceuticals AB

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Selective Supplies Ltd

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Teva UK Limited

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

Zydus Pharmaceuticals UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2027

£17,727,000

AFT Pharma UK

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Arcadia Pharma Ltd T/A Arcadia Medical

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

AGB Pharma

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Flynn Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Accord UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Aguettant Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Alturix Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

AOP Orphan Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Ascend Laboratories UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Ascot Laboratories Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Aspen Pharmacare UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Aspire Pharma Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Aventis Pharma ltd t/a Sanofi

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

B Braun Medical Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Baxter Healthcare Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Beaumont Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Biocon

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Bowmed Ibisqus Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Chiesi Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Colonis Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Crescent Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

CST Pharma Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Day Lewis Medical Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Desitin Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Drugsrus Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Ennogen Healthcare Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Eramol (UK) Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Essential Pharma

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Esteve Pharmaceuticals Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Flexipharm Austrading Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Fontus Health Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Fresenius Kabi Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

G.L. Pharma UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Galen Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Galvany Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Gennisium Pharma

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

GlaxoSmithKline UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Glenmark Pharmaceuticals Europe Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Green Park Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Grindeks Kalceks UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Hameln Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Hikma Pharmaceuticals

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

JCSH Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Kent Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Leo Pharma

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Lipomed AG

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

LogixX Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Lucane Pharma

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Lundbeck Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Macleods Pharma UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Macure Pharma ApS

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Martindale Pharma

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

medac Pharma LLP

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Merck Sharpe & Dohme (UK) Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Mercury Pharmaceuticals

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Milpharm Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

MSN Laboratories Europe Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Necessity Supplies Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Neon Healthcare Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Neuraxpharm UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Northumbria Pharma Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Orifarm UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Otsuka Pharmaceuticals UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Panpharma UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Pari Medical Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Perennial Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Pfizer Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Phoenix Lab

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Piramal Critical care Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Reig Jofre UK limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Roma Pharmaceuticals Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

ROVI Biotech Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Sandoz Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Seacross Pharmaceuticals Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Stirling Anglian Pharmaceuticals Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Strides Pharma UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Sun Pharma UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

SVP Pharma Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Synchrony

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Takeda UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Thea Pharmaceuticals Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Thornton and Ross Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Tillomed Laboratories ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Torbay Pharmaceuticals

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Torrent Pharma UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Vantage Pharmaceuticals Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Waymade PLC

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Wockhardt UK Limited

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Zentiva Pharma UK Ltd

13 Jan 20261 Jun 2026 – 31 May 2028

£403,702,000

Likely incumbents

Suppliers who won similar work from this buyer in the last 5 years.

5 found
  1. 1

    Sheffield Teaching Hospitals NHS Foundation Trust

    7 contracts wonlatest 22 Sept 2026

    £780m

    total awarded

  2. 2

    The Newcastle upon Tyne Hospitals NHS Foundation Trust

    7 contracts wonlatest 22 Sept 2026

    £794m

    total awarded

  3. 3

    Accord UK Ltd

    7 contracts wonlatest 27 Aug 2026ends 31 Jan 2029

    £2bn

    total awarded

  4. 4

    NHS Business Services Authority

    6 contracts wonlatest 29 Sept 2026ends 31 Mar 2027

    £55m

    total awarded

  5. 5

    MILPHARM LIMITED

    6 contracts wonlatest 27 Aug 2026ends 31 May 2030

    £1bn

    total awarded

Sheffield Teaching Hospitals NHS Foundation Trust is the most likely incumbent based on recency and category match. To win, bidders typically need a clearly differentiated proposition or a price advantage.

Search for tenders
SponsoredEst. 2010
Gladstone & Co AccountantsTax advisers · East Ham, London

Before you bid, buyers check

two years of filed accountsyour financial standingturnover vs contract valueyour Companies House recordcash flow for 30-day termscredit scores and ratios

Annual accountsCash-flow forecastsManagement accountsCorporation taxVAT & MTDPayroll & RTIBookkeepingCompany formationSelf-assessmentVirtual FDHMRC enquiriesAuto-enrolmentProperty & landlord taxCharity SORP accounts
Get bid-ready — free 30-min call

Actions

Start free trialto open notice

Create an account and start a 7-day free trial to open the buyer’s own notice and tender documents, plus fit scoring and the Bid Writer. Then £4.99/month — cancel anytime.

Open Bid Writer
Built by · Digital studioEst. 2022
Unique
Evolution®

Independent software, web & cloud studio. We design, build and grow digital products that quietly outlast their category.

Web DesignSoftware DevelopmentSEO ServicesPromotion
Visit Unique Evolution

How to Apply

Step-by-step submission guide

Closed

Submission Portal

Find a Tender

Visit
1

Open the original notice

Click the button below to view the full notice on Find a Tender Service (FTS)

2

Check the procedure type

The "Procedure" section tells you if it's Open (one stage) or Restricted (SQ then ITT). This changes how you apply

3

Access the eSourcing portal

FTS notices link to the buyer's eSourcing platform — register there to access documents

4

Complete the Selection Questionnaire

Higher-value contracts often require an SQ first — this pre-qualifies you before the full bid stage

5

Submit electronically

Upload your completed response through the eSourcing platform before the closing date and time

FTS contracts are above UK procurement thresholds. Late submissions are strictly rejected — submit at least 24 hours before the deadline to avoid portal issues.

Buyer Profile

NHS England
Typepublic body
RegionNorth East,North West,Yorkshire and The Humber,East Midlands,West Midlands,East of England,London,South East,South West,Scotland,Wales,Northern Ireland
Total tenders1,496
Total spend£160,377,968,665
View buyer profile

Key Dates

Published

26 February 2026

Submission deadline

10 October 2025

Notice type

award

Source

find a tender